Advertisement

Drug Nephrolithiasis: An Unrecognized and Underestimated Pathology

  • M. Daudon
  • R. J. Reveillaud

Abstract

The occurrence of drugs in urinary stones is a rare finding. Apart from Ettinger’s studies on triamterene1, the only other papers are confined to individual, isolated cases. When a stone is present, the contribution of drugs to nucleation or growth should always be considered.

Keywords

Renal Pelvis Urinary Stone Ester Sulfate Magnesium Carbonate Uricosuric Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    B. Ettinger, N. O. Oldroyd, and F. Sorgel, J. Am. Med. Assoc. 244:2443 (1980).CrossRefGoogle Scholar
  2. 2.
    M. Daudon, M. F. Protat, and R. J. Reveillaud, Ann. Biol. Clin. 36:475 (1978).Google Scholar
  3. 3.
    N. Daudon, M. F. Protat, and R. J. Reveillaud, Nephrol. 3:119 (1982).Google Scholar
  4. 4.
    M. Daudon, M. F. Protat, and R. J. Reveillaud, Ann. Biol. Clin. 41:105 (1983).Google Scholar
  5. 5.
    W. J. Johnson and A. Chartrand, Toxicol. Appl. Pharmacol. 37:371 (1976).PubMedCrossRefGoogle Scholar
  6. 6.
    M. Daudon, M. F. Protat, and R. J. Reveillaud, Ann. Biol. Clin. 41:239 (1983).Google Scholar
  7. 7.
    M. Daudon and R. J. Reveillaud, Nephrol. (in press).Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • M. Daudon
    • 1
  • R. J. Reveillaud
    • 1
  1. 1.Crystal Laboratory and Dept. of Internal Medicine and NephrologyCentre HospitalierSaint-CloudFrance

Personalised recommendations